Furthermore, HF patients with elevated FD levels (i.e., above 1.7 μg/mL), and TCC levels (i.e., above 2.6 CAU/mL), had significantly higher Nt-proBNP and CRP levels (Fig. 3e–h), but had the same LVEF and clinical outcome as HF patients with normal FD levels (data not shown). The gene discussed is CRP; the disease is hydrops fetalis.